» Articles » PMID: 34943076

Exploring Early Detection of Frailty Syndrome in Older Adults: Evaluation of Oxi-Immune Markers, Clinical Parameters and Modifiable Risk Factors

Overview
Date 2021 Dec 24
PMID 34943076
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Ageing is accompanied with a decline in several physiological systems. Frailty is an age-related syndrome correlated to the loss of homeostasis and increased vulnerability to stressors, which is associated with increase in the risk of disability, comorbidity, hospitalisation, and death in older adults. The aim of this study was to understand the relationship between frailty syndrome, immune activation, and oxidative stress. Serum concentrations of vitamins A and E were also evaluated, as well as inflammatory biomarkers (CRP and IL-6) and oxidative DNA levels. A group of Portuguese older adults (≥65 years old) was engaged in this study and classified according to Fried's frailty phenotype. Significant increases in the inflammatory mediators (CRP and IL-6), neopterin levels, kynurenine to tryptophan ratio (Kyn/Trp), and phenylalanine to tyrosine ratio (Phe/Tyr), and significant decreases in Trp and Tyr concentrations were observed in the presence of frailty. IL-6, neopterin, and Kyn/Trp showed potential as predictable biomarkers of frailty syndrome. Several clinical parameters such as nutrition, dependency scales, and polypharmacy were related to frailty and, consequently, may influence the associations observed. Results obtained show a progressive immune activation and production of pro-inflammatory molecules in the presence of frailty, agreeing with the inflammageing model. Future research should include different dimensions of frailty, including psychological, social, biological, and environmental factors.

Citing Articles

Determination of 3-hydroxyanthranilic acid in the sweat of healthy older adults.

Katewongsa K, Manohong P, Trangan Y, Palakai R, Mysook S, Mantim T Sci Rep. 2024; 14(1):25396.

PMID: 39455712 PMC: 11511813. DOI: 10.1038/s41598-024-76956-z.


A multicomponent personalized prevention program in the primary care setting: a randomized clinical trial in older people with noncommunicable chronic diseases (Primacare_P3 study).

Pilotto A, Barbagelata M, Lacorte E, Custodero C, Veronese N, Maione V Trials. 2024; 25(1):611.

PMID: 39272196 PMC: 11395640. DOI: 10.1186/s13063-024-08413-1.


Frailty is related to serum inflammageing markers: results from the VITAL study.

van Sleen Y, Shetty S, van der Heiden M, Venema M, Gutierrez-Melo N, Toonen E Immun Ageing. 2023; 20(1):68.

PMID: 38012652 PMC: 10680197. DOI: 10.1186/s12979-023-00391-3.


Toxoplasma gondii IgG Serointensity Is Positively Associated With Frailty.

Mohyuddin H, Laffon B, Teixeira J, Costa S, Teixeira-Gomes A, Pasaro E J Gerontol A Biol Sci Med Sci. 2023; 79(3).

PMID: 37939652 PMC: 10851338. DOI: 10.1093/gerona/glad228.


Systematic oxidative stress indices predicts prognosis in patients with urothelial carcinoma of the upper urinary tract after radical nephroureterectomy.

Liu J, Lai S, Wu P, Wang J, Wang J, Wang J Eur J Med Res. 2023; 28(1):469.

PMID: 37898799 PMC: 10612206. DOI: 10.1186/s40001-023-01295-0.


References
1.
Sousa-Santos A, Afonso C, Moreira P, Padrao P, Santos A, Borges N . Weakness: The most frequent criterion among pre-frail and frail older Portuguese. Arch Gerontol Geriatr. 2017; 74:162-168. DOI: 10.1016/j.archger.2017.10.018. View

2.
Theofylaktopoulou D, Midttun O, Ulvik A, Ueland P, Tell G, Vollset S . A community-based study on determinants of circulating markers of cellular immune activation and kynurenines: the Hordaland Health Study. Clin Exp Immunol. 2013; 173(1):121-30. PMC: 3694542. DOI: 10.1111/cei.12092. View

3.
Collerton J, Martin-Ruiz C, Davies K, Hilkens C, Isaacs J, Kolenda C . Frailty and the role of inflammation, immunosenescence and cellular ageing in the very old: cross-sectional findings from the Newcastle 85+ Study. Mech Ageing Dev. 2012; 133(6):456-66. DOI: 10.1016/j.mad.2012.05.005. View

4.
Rodriguez-Artalejo F, Rodriguez-Manas L . The frailty syndrome in the public health agenda. J Epidemiol Community Health. 2014; 68(8):703-4. DOI: 10.1136/jech-2014-203863. View

5.
Fedarko N . The biology of aging and frailty. Clin Geriatr Med. 2010; 27(1):27-37. PMC: 3052959. DOI: 10.1016/j.cger.2010.08.006. View